We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.34B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
4.72%
Top 10 Hldgs %
12.01%
Holding
1,564
New
189
Increased
576
Reduced
529
Closed
163

Sector Composition

Rank Sector Weight
1 Energy 11.94%
2 Healthcare 10.62%
3 Industrials 9.8%
4 Technology 9.43%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$132B
$19.3M 0.58%
372,070
+47,478
+15% +$2.53M
BRK.B icon
27
Berkshire Hathaway Class B
BRK.B
$1.1T
$18.7M 0.56%
149,305
-6,055
-4% -$708K
VWO icon
28
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$18.5M 0.55%
455,148
-34,086
-7% -$1.32M
COP icon
29
ConocoPhillips
COP
$145B
$18.2M 0.55%
259,126
-1,301
-0.5% -$87.1K
AFL icon
30
Aflac
AFL
$64.8B
$18.2M 0.54%
576,080
+21,640
+4% +$688K
IVV icon
31
iShares Core S&P 500 ETF
IVV
$872B
$18.1M 0.54%
96,455
+6,636
+7% +$1.23M
F icon
32
Ford
F
$59.3B
$17.7M 0.53%
1,131,662
-33,051
-3% -$511K
META icon
33
Meta Platforms (Facebook)
META
$1.37T
$17.6M 0.53%
292,908
+35,401
+14% +$2.24M
DD
34
DELISTED
Du Pont De Nemours E I
DD
$16.7M 0.5%
262,352
+72,023
+38% +$4.41M
IWN icon
35
iShares Russell 2000 Value ETF
IWN
$14.4B
$16.7M 0.5%
165,403
+107,191
+184% +$10.6M
VTI icon
36
Vanguard Morningstar Total Stock Market ETF
VTI
$657B
$16.5M 0.49%
+169,083
New +$16.2M
GLF
37
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$15.9M 0.48%
354,329
+3,500
+1% +$155K
OXY icon
38
Occidental Petroleum
OXY
$55.6B
$15.7M 0.47%
171,791
+23,537
+16% +$2.1M
COST icon
39
Costco
COST
$423B
$15.3M 0.46%
137,020
+5,161
+4% +$590K
IGSB icon
40
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$14.9M 0.45%
283,454
-270
-0.1% -$14.2K
FCX icon
41
Freeport-McMoran
FCX
$91.2B
$14.5M 0.44%
439,830
+24,985
+6% +$832K
PEP icon
42
PepsiCo
PEP
$191B
$14.4M 0.43%
172,500
+4,362
+3% +$354K
EHC icon
43
Encompass Health
EHC
$11B
$14M 0.42%
488,958
-2,011
-0.4% -$52.3K
MO icon
44
Altria Group
MO
$113B
$13.8M 0.41%
368,750
+22,913
+7% +$833K
ILMN icon
45
Illumina
ILMN
$31B
$13.6M 0.41%
94,211
-16,965
-15% -$2.49M
QQQ icon
46
Invesco QQQ Trust
QQQ
$450B
$13.6M 0.41%
154,834
+2,527
+2% +$223K
BP icon
47
BP
BP
$114B
$13.1M 0.39%
334,049
+19,050
+6% +$751K
DUK icon
48
Duke Energy
DUK
$98.4B
$13.1M 0.39%
183,407
+25,354
+16% +$1.77M
BA icon
49
Boeing
BA
$175B
$13M 0.39%
103,556
+3,816
+4% +$497K
AMGN icon
50
Amgen
AMGN
$209B
$12.5M 0.38%
101,421
+22,518
+29% +$2.73M

Similar funds

Oppenheimer & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Oppenheimer & Co held 1,564 positions worth $3.34B, up 6.7% from $3.13B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co deployed $157M of net new capital in Q1 2014, opening 189 new positions and adding to 576 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $7.79M trimmed.

  • Oppenheimer & Co's largest Q1 2014 buy was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.
  • Oppenheimer & Co added most to Monsanto Co in Q1 2014, an estimated $30M increase.
  • Oppenheimer & Co's biggest Q1 2014 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $7.79M.
  • Oppenheimer & Co fully exited TetraLogic Pharmaceuticals Corporation in Q1 2014, selling an estimated $10.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.34B portfolio in Q1 2014.
  • Oppenheimer & Co opened 189 new positions and closed 163 in Q1 2014.
  • Oppenheimer & Co's portfolio value rose 6.7% quarter-over-quarter to $3.34B.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.